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•Neuroimaging is a diagnostic tool that may be 
used to rule out a serious condition when a 
patient presents with head pain. It is not 
typically warranted for patients who have a 
normal neurologic exam, and may be over-
utilized despite established practice parameters 
set by the American Academy of Neurology.1,2
•A decision to use neuroimaging should consider 
the type of headache and presence of any 
clinical features that suggest a serious 
condition.3
•Over-utilization of neuroimaging has cost and 
safety implications.4-6
•The United States Headache Consortium, a 
panel of experts on migraine, set the guidelines 
for diagnosis and treatment in 2000. In 
alignment with these guidelines, the Migraine 
Quality of Care Measurement Set seeks to 
reveal patterns in CT and MRI utilization for 
migraine sufferers, which may inform future 
policy decisions at the health plan-level.7
•The Migraine Quality of Care Measurement Set 
was developed to examine utilization of 
services within a health plan to identify 
potential quality and safety concerns 
associated with care for the population 
identified with migraine. 
•A set of measures were originally developed in 
2007,8,9 by the Jefferson School of Population 
Health and the Jefferson Headache Center, 
with input from a national panel of advisors 
with clinical expertise in migraine.
•The measures and measurement specifications 
were updated in 2010 to align with current 
evidence. 
•A pilot test of the 2010 measures was then 
conducted, using data from 10 health plans.  
•The measurement set covers five areas of 
migraine diagnosis and treatment:
1. Establishment of Diagnosis
2. Utilization of Radiologic Services
3. Utilization of Physician Services
4. Utilization of Urgent and Emergent Services
5. Utilization of Migraine Medications
•The intent of the measures is to allow plans to 
examine their utilization over time, and in 
relation to national benchmarks.
Study Aims
•As part of the 10-plan pilot test of the 
measures, the aims of this study were:
1. To examine the current utilization rates for CT 
scans and MRIs in the insured migraine 
population.
2. To examine variability in CT and MRI utilization 
rates across health plans and establish national 
utilization benchmarks.
Methods: Study Population
•Ten representative commercial and/or Medicaid 
health plans in the MedAssurant Medical 
Outcomes Research for Effectiveness and 
Economics Registry (MORE2 Registry™) were 
included in the study.
•The reporting year (the year of claims data on 
which measurement was based) was 2009.
•Only adult members between ages 18 and 64, 
with medical benefits, were eligible for 
inclusion (N ≈ 2.9 million, across the 10 plans). 
•The migraine population was identified through 
claims (ICD-9 and UB-04 codes) and pharmacy 
data (where available) as patients having at 
least one of the following criteria:
- 1 or more claim(s)/encounter(s) for migraine, or
- 2 or more “episodes” of headache reflected by  
multiple claims/encounters (“recurrent 
headache”) >7 days apart, or
- 1 or more prescription(s) for a triptan or migraine 
analgesic
• Individuals with a diagnosis of subarachnoid 
hemorrhage, brain tumor, and/or intracranial 
bleed were excluded.
Results
Identification of the Migraine
Population
Measures on Utilization of
Radiologic Services
*Percentage represents scans rather than patients
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Key Findings
• Twelve percent of the Migraine Population had a 
CT scan for migraine during the measurement 
year, and 8% had an MRI. While some variation in 
the utilization rate for MRIs was observed across 
the 10 plans (6-11%), far greater variation was 
seen for CT scans (8-25%).
• Seventy-three percent of all CT scans for migraine 
were completed within 48 hours of an emergency 
department (ED) visit, but again, significant 
variation across plans was noted.
• More than half of all neuroimaging tests (CT scans 
and MRIs) were not associated with an ED visit.
• A small portion of the Migraine Population (2%) 
had multiple CT and/or MRI scans during the one 
year examined.  
Discussion: The Migraine Quality
of Care Measurement Set
• This examination of the radiologic services 
utilization measures included in the Migraine 
Quality of Care Measurement Set demonstrates 
the potential value of the measures to identify 
utilization trends.  
• In addition to identifying a general concern about 
potential over-utilization of neuroimaging in the 
population with migraine, the pilot test 
demonstrates significant variation in the measures 
across health plans. 
• The measures can be of value to health plans in 
identifying potential quality and safety issues and 
comparing their performance with national 
benchmarks.
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Migraine Population identified: Members (n)
Criterion 1: 
1 or more claim(s)/encounter(s) for migraine
36,579
Criterion 2: 
2 or more “episodes” of headache reflected by multiple 
claims/encounters (“recurrent headache”)  >7 days apart
21,718
Criterion 3: 
1 or more prescription(s) for a migraine drug or migraine 
analgesic
36,223
Met more than one criteria 43,484
Total identified population 138,004
*RA is the code applied to the radiology utilization subset of the Migraine Quality of 
Care Measurement Set
⁺Any combination of CT and MRI scans are captured by this measure (i.e. multiple CT 
scans, multiple MRI scans or a combination of the two)
Measure* Numerator Denominator
RA.1 A CT scan of the head and/or 
sinuses for migraine
All patients with one or more CT 
scans of the head and/or sinuses 
for migraine.
All patients in the Migraine 
Population. 
RA.2 A CT scan of the head and/or 
sinuses associated with an ED visit
All CT scans of the head and/or 
sinuses for migraine within 48 
hours of an ED visit.
All CT scans of the head and/or 
sinuses for migraine.
RA.3 A CT or MRI scan of the head 
and/or sinuses for migraine not 
associated with an ED visit
All CT or MRI scans of the head 
and/or sinuses for migraine not 
occurring on the same date as an 
ED visit.
All CT or MRI scans of the head 
and/or sinuses for migraine.
RA.4 An MRI of the head and/or 
sinuses for migraine
All patients with an MRI of the 
head and/or sinuses for migraine.
All patients in the Migraine 
Population. 
RA.5 Multiple CT or MRI scans for 
migraine
All patients with more than one 
CT or MRI scan for migraine.+
All patients in the Migraine 
Population. 
Measure
Overall 
finding 
(%)
Median value 
across 10 
health plans 
(%)
Range across 10 
health plans 
(%)
RA.1 CT Scan
(Patients with >1 CT Scan/Migraine Population)
12.47 11.18 7.71 – 24.50
RA.2 CT Scan associated with an ED visit*
(CT Scan for migraine within 48 hours of an ED All CT Scans)
73.21 74.02 58.68 – 86.18
RA.3 CT Scan or MRI not associated with an ED 
visit*
(CT or MRI Scan not during an ED visit/All CT or MRI scans)
53.02 55.58 37.70 – 66.78
RA.4 MRI Scan
(Patients with an MRI Scan/Migraine Population)
8.27 8.77 6.02- 10.72
RA.5 Multiple Scans
(Patients with >1 CT or MRI Scans/Migraine Population)
2.23 1.83 1.07 – 6.00
Radiology Utilization Across 10 Health Plans
